68 related articles for article (PubMed ID: 548938)
1. Clinical advances in oral antibiotic therapy. Summary and closing remarks.
Neu HC
Postgrad Med J; 1979; 55 Suppl 4():100-1. PubMed ID: 548938
[No Abstract] [Full Text] [Related]
2. Laboratory and clinical studies of cefaclor in Japan.
Fujii R
Postgrad Med J; 1979; 55 Suppl 4():88-92. PubMed ID: 398486
[No Abstract] [Full Text] [Related]
3. Cefaclor--summary of clinical experience.
Kammer RB; Short LJ
Postgrad Med J; 1979; 55 Suppl 4():93-9. PubMed ID: 548945
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of acute bacterial pneumopathies with cefaclor].
Pasternak J; Levi GC; Nakasu EV; Nitrini DR; Amato Neto V
Rev Inst Med Trop Sao Paulo; 1980; 22(6):303-5. PubMed ID: 7244517
[No Abstract] [Full Text] [Related]
5. Cefaclor safety profile: a ten-year review.
Hyslop DL
Clin Ther; 1988; 11 Suppl A():83-94. PubMed ID: 3242837
[No Abstract] [Full Text] [Related]
6. [Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
Leveque B; Lambert-Zechovsky N; Cathlin C
Ann Pediatr (Paris); 1980 Jun; 27(6):405-8. PubMed ID: 7013629
[No Abstract] [Full Text] [Related]
7. Therapy of acute bacterial infections with cefaclor in a pediatric population: an open assessment.
Iancu TC; Sinoff G
Isr J Med Sci; 1983 Nov; 19(11):998-1000. PubMed ID: 6662693
[TBL] [Abstract][Full Text] [Related]
8. Cefaclor--a new oral cephalosporin.
Drug Ther Bull; 1979 Aug; 17(18):69-70. PubMed ID: 498945
[No Abstract] [Full Text] [Related]
9. Influence of amoxycillin and cefaclor on the colonization resistance of oropharynx.
van Saene HK; Willems FT; Zweens J
Scand J Infect Dis Suppl; 1983; 39():97-9. PubMed ID: 6359384
[TBL] [Abstract][Full Text] [Related]
10. [Clinical results of cefaclor treatment of infections of oral regions].
Yoshida Y; Kita T; Kanematsu N; Sato K; Kawata K; Fukuta N; Sato J
Jpn J Antibiot; 1984 Mar; 37(3):318-28. PubMed ID: 6737694
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cefaclor.
Derry JE
Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
[TBL] [Abstract][Full Text] [Related]
12. Cefaclor treatment of upper and lower respiratory tract infections caused by Moraxella catarrhalis.
Oberlin JA; Hyslop DL
Pediatr Infect Dis J; 1990 Jan; 9(1):41-4. PubMed ID: 2105479
[TBL] [Abstract][Full Text] [Related]
13. [Use of cefaclor monohydrate in infections of the upper and lower respiratory tract].
Abbatangelo R; Mascelloni R; Cavani E; Prete C
Clin Ter; 1988 Aug; 126(4):261-5. PubMed ID: 2974395
[No Abstract] [Full Text] [Related]
14. [Review [new antibiotics series V]: cefaclor (author's transl)].
Fujii R
Jpn J Antibiot; 1982 Mar; 35(3):714-23. PubMed ID: 7047791
[No Abstract] [Full Text] [Related]
15. Summary of laboratory studies on the antibacterial activity of cefaclor.
Preston DA
Infection; 1979; 7 Suppl 6():557-61. PubMed ID: 45088
[TBL] [Abstract][Full Text] [Related]
16. [Cefaclor in the treatment of respiratory tract infections in children].
Klech H; Stur O; Götz M
Padiatr Padol; 1985; 20(3):297-306. PubMed ID: 4034220
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory studies with cefaclor: efficacy in skin and soft tissue infections.
Dillon HC; Gray BM; Ware JC
Postgrad Med J; 1979; 55 Suppl 4():77-81. PubMed ID: 548944
[TBL] [Abstract][Full Text] [Related]
18. Cefaclor in the management of common bacterial skin diseases.
Finnerty EF; Folan DW
Cutis; 1979 Sep; 24(3):304-6. PubMed ID: 477398
[No Abstract] [Full Text] [Related]
19. Cefaclor in the treatment of skin, soft tissue, and urinary tract infections: a review.
Verhoef J
Clin Ther; 1988; 11 Suppl A():71-82. PubMed ID: 3072089
[No Abstract] [Full Text] [Related]
20. Clinical and bacteriological evaluation of cefaclor and tetracycline in acute episodes of bacterial bronchitis.
Smialowicz CR
Clin Ther; 1982; 5(2):113-9. PubMed ID: 7159894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
